788 related articles for article (PubMed ID: 32888236)
1. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
2. An emerging role for cellular crosstalk in the cancer stem cell niche.
Oshimori N; Guo Y; Taniguchi S
J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
[TBL] [Abstract][Full Text] [Related]
3. Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression.
Taniguchi S; Elhance A; Van Duzer A; Kumar S; Leitenberger JJ; Oshimori N
Science; 2020 Jul; 369(6501):. PubMed ID: 32675345
[TBL] [Abstract][Full Text] [Related]
4. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
[TBL] [Abstract][Full Text] [Related]
5. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
7. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
8. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling.
Schober M; Fuchs E
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10544-9. PubMed ID: 21670270
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
Huang H; Wang C; Liu F; Li HZ; Peng G; Gao X; Dong KQ; Wang HR; Kong DP; Qu M; Dai LH; Wang KJ; Zhou Z; Yang J; Yang ZY; Cheng YQ; Tian QQ; Liu D; Xu CL; Xu DF; Cui XG; Sun YH
Clin Cancer Res; 2018 Sep; 24(18):4612-4626. PubMed ID: 29691294
[No Abstract] [Full Text] [Related]
12. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
14. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
[TBL] [Abstract][Full Text] [Related]
16. Perivascular stem cell niche in head and neck cancer.
Ritchie KE; Nör JE
Cancer Lett; 2013 Sep; 338(1):41-6. PubMed ID: 22842095
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells in Squamous Cell Carcinoma.
Jian Z; Strait A; Jimeno A; Wang XJ
J Invest Dermatol; 2017 Jan; 137(1):31-37. PubMed ID: 27638386
[TBL] [Abstract][Full Text] [Related]
19. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
